scholarly journals Vaccines for Mycoplasma Diseases of Small Ruminants: A Neglected Area of Research

Pathogens ◽  
2022 ◽  
Vol 11 (1) ◽  
pp. 75
Author(s):  
Katarzyna Dudek ◽  
Umit Sevimli ◽  
Sergio Migliore ◽  
Amirreza Jafarizadeh ◽  
Guido R. Loria ◽  
...  
Keyword(s):  
Animal Health ◽  
Small Ruminants ◽  
Poor Quality ◽  
Atypical Pneumonia ◽  
Live Vaccines ◽  
Limited Impact ◽  
Contagious Agalactia ◽  
Contagious Caprine Pleuropneumonia ◽  
The World ◽  
World Organisation

Mycoplasmas cause some of the most economically important diseases of sheep and goats, including diseases listed by the World Organisation for Animal Health (OIE) such as contagious caprine pleuropneumonia (CCPP) and contagious agalactia (CA). Other important mycoplasma diseases include chronic respiratory and arthritic syndrome (CRAS) and atypical pneumonia, both present on all continents where small ruminants are farmed. Unfortunately, owing to a lack of investment, most commercial vaccines for these diseases are of poor quality, being mostly composed of killed bacteriocins of dubious or unknown efficacy. Several Mediterranean laboratories produce autogenous vaccines, but these can only be used on farms where outbreaks have been officially declared, and consequently have limited impact on disease nationally. Effective live vaccines are available, but their use is often restricted because of safety concerns. With the necessary safeguards in place, we argue for their greater use. This review examines reported vaccines for mycoplasma diseases of small ruminants and attempts to identify new candidate antigens that may enable the development of improved products. Vaccines for CCPP are covered elsewhere.

​Caprine Respiratory Mycoplasmosis (Contagious Caprine Pleuropneumonia CCPP)- A Global Perspective of the Disease, Epidemiology, Diagnosis, Chemotherapy and Immunization: A Review

2021 ◽  
Author(s):  
M. Shaheen ◽  
S. Bashir ◽  
N. Hassan ◽  
Z.A. Akhoon ◽  
A. Muhee
Keyword(s):  
Animal Health ◽  
Small Ruminants ◽  
Global Perspective ◽  
Effective Vaccine ◽  
Febrile Reaction ◽  
High Morbidity ◽  
Atypical Pneumonia ◽  
Mycoplasma Infection ◽  
Mycoplasma Capricolum ◽  
Contagious Caprine Pleuropneumonia

Mycoplasma infection of the respiratory tract of goats is prevalent worldwide including the South Asian sub-continent. Owing to intensive and large scale goat farming, the incidence of the disease is on an increase. Among various species of mycoplasma, Mycoplasma capricolum subspecies Capri pneumoniae is increasingly incriminated in Contagious Caprine Pleurapneumonia (CCPP) in goat populations with considerable economic fallout in the form of high morbidity and mortality. The disease manifestations in caprines are recorded as anorexia, high febrile reaction and respiratory embarrassment in the shape of clinical dyspnoea, polypnea, paroxysmal cough and sero-purulent nasal discharges. The disease is thus contracted by the healthy animals through aerosol, contaminated feed and water sources in the herd premises, without a protective immunity and that the conferred immunity in recovered cases being short-lived. The true lesions of CCPP are confined to the lung alveolar tissues of infected goats, which distinguish it from other respiratory diseases of small ruminants caused by the members of the Mycoplasma mycoides cluster. Atypical pneumonia caused by the mycoplasma infection of goats, also known as Contagious Caprine Pleuropneumonia (CCPP) has been more often reported from Africa and Asia than Europe. Classical, acute CCPP attributed to Mycoplasma capricolum subsp. Capri pneumoniae, originally known asthe F38 biotype (World Organisation for Animal Health, 2008) causes heavy kid mortality. Two other organisms in this group, M. mycoides subsp. capri and M. mycoides subsp. mycoides large-colony type, can cause disease in small ruminants that clinico-pathologically mimics CCPP but may have extra pulmonary signs and lesions, sometimes. Mycoplasma Capri pneumoniae and other members of the M. mycoides cluster cross-react in serological tests and share biochemical and genetic similarities. The most favourable epidemiological scenario in the Sub-continent is the hot humid climate during monsoons. The diversity and multi-etiological subspecies involved in the disease is detrimental in the development of an effective vaccine even though in some places a liquid vaccine is presently in use. At other places, anti-mycoplasmal antibiotics of aminoglycoside and fluoroquinolone and perhaps the macrolide groups remain to be the main option in preventing flock mortalities.

scholarly journals Diseases of Gastropoda

2022 ◽  
Vol 12 ◽  
Author(s):  
Michelle F. O’Brien ◽  
Sarah Pellett
Keyword(s):  
Fresh Water ◽  
Food Source ◽  
Negative Impact ◽  
Animal Health ◽  
Etiological Agent ◽  
Human Consumption ◽  
Intermediate Hosts ◽  
The World ◽  
Herpesvirus 1 ◽  
World Organisation

Gastropods (class Gastropoda) form the largest of the classes in the phylum Mollusca and inhabit terrestrial, fresh water and marine environments. A large number of these species are of major conservation importance and are an essential component of ecosystems. Gastropods may be deemed as pests, having a negative impact in horticulture and agriculture, whereas others may be used as a food source for human consumption and therefore are beneficial. Gastropods are susceptible to primary diseases and also act as intermediate hosts for diseases which affect other animals, including humans. The diseases described include two that are notifiable to the World Organisation for Animal Health (OIE): Xenohaliotis californiensis and Abalone viral ganglioneuritis caused by Haliotid herpesvirus-1 (HaHV-1). Research into the diseases of gastropods has often focused on those species that act as intermediate disease hosts, those that are used in research or those cultured for food. In this paper we review the viral, bacterial, fungal, parasitic and miscellaneous conditions that have been reported in gastropods and mention some of the factors that appear to predispose them to disease. The pathogenicity of a number of these conditions has not been fully ascertained and more research is needed into specifying both the etiological agent and significance in some of the diseases reported.

scholarly journals Occurrence of peste des petits ruminants and its increasing threat to Europe

2019 ◽  
Vol 75 (02) ◽  
pp. 6209-2019
Author(s):  
WIESŁAW NIEDBALSKI
Keyword(s):  
West Africa ◽  
Indian Subcontinent ◽  
Animal Health ◽  
Small Ruminants ◽  
Global Strategy ◽  
High Morbidity ◽  
Peste Des Petits Ruminants ◽  
The European Union ◽  
Increased Risk ◽  
The World

Peste des petits ruminants (PPR) is a highly contagious disease of small ruminants that leads to high morbidity and mortality, and thereby results in devastating economic consequences to the livestock industry. It is caused by the PPR virus (PPRV), which belongs to the genus Morbilivirus in the family Paramyxoviridae. PPR was first recorded in early 1942 in Ivory Coast, West Africa. In the following years, the disease extended its distribution to other parts of the world and now circulates throughout Northern, Eastern and West Africa, as well as Asia – in particular, China, Central Asia, Eurasia, the Indian subcontinent and the Middle East. The molecular epidemiology of PPRV, based on the sequence comparison of a small region of either the N or the F gene, has revealed the existence of four distinct lineages (I-IV) of the virus. Until June 2018, PPR had never been detected in Europe, with the exception of the European part of Turkish Thrace. However, on 24th June 2018 the Bulgarian authorities reported cases of PPR in sheep in the village of Voden, Bolyarovo municipality of Yambol region, on the border with the Thrace region of Turkey. It was the first occurrence of PPR in Bulgaria and in the European Union (EU). The source of PPR infection in Bulgaria is not clear, it could have been the illegal movement of animals, contaminated materials or humans, e.g. refuges. Due to the increased risk of introduction of PPR from North Africa and Turkey to neighbouring regions, the European Food Safety Authority (EFSA) has recently published a report assessing the risk of PPR spreading in Europe. According to a scientific opinion by the EFSA, the spread of PPRV in the territory of the UE could occur by the illegal transport of infected animals or infected animal products. In order to limit the spread and impact of PPR outbreaks in Europe, rapid detection, movement restriction, prompt culling of infected herds and disinfection measures should be introduced immediately. The control and eventual eradication of PPR is now one of the top priorities for the Food and Agriculture Organization (FAO) and the World Organization for Animal Health (OIE). In 2015, the international community agreed on a global strategy for PPR eradication, setting 2030 as a target date for elimination of the disease.

Taiwan’s Participation in the World Organisation for Animal Health (oie): Modalities, Utility, and Challenges

2021 ◽  
pp. 1-33
Author(s):  
Vincent Rollet
Keyword(s):  
Global Health ◽  
Health Management ◽  
Animal Health ◽  
Global Health Security ◽  
International Organisations ◽  
Health Governance ◽  
Health Security ◽  
The World ◽  
Health Related ◽  
World Organisation

Abstract This article explores the utility of membership in international organisations for states with specific status within the international community, focusing on Taiwan’s surprisingly neglected involvement in the World Organisation for Animal Health or oie (Office International des Épizooties). The paper shows that in addition to its contribution to the legitimisation of Taiwan’s identities, such participation has also enabled Taiwan to shape international norms in the field of animal health, increase international cooperation opportunities, strengthen domestic and global health security, and facilitate the trade of animal health-related products. Additionally, it has contributed to the domestic implementation of international animal health norms and helped increase the accountability of Taiwanese authorities in the domain of animal health management. Despite tremendous challenges, Taiwan still has plenty of opportunities to enhance its participation in global health governance through its membership in oie.

Sign in / Sign up

Export Citation Format

Share Document